ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Gladstone Institutes
The Gladstone-UCSF Institute of Genomic Immunology is recruiting a Research Associate to support studies on genetic engineering and functional assessment of T cell therapies, focusing on cutting-edge technologies like CRISPR to develop novel cancer immunotherapies using engineered human immune cells.
Headquarters
San Francisco, California, United States
Company Size
201-500 employees
Founded
1979
We are overcoming unsolved diseases through transformative biomedical research.
The Business JournalsViewpoint: NIH funding cuts will cost lives and threaten innovation
Sep 11, 2025
Baylor College of Medicine Blog Network -Collaboration to Advance Immune-Targeted Drug Discovery at Baylor College of Medicine
Sep 25, 2025
WebWireTopos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins Driving Alzheimer’s and Cancer
Jan 8, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Gladstone Institutes.
12% below the average for this role
Lab-grown salmon introduced by Bay Area-based cultivated seafood company Wyldtype
Aug 8, 2025
Microbiologist III
IHRC
Research Assistant-Genetics
Endeavor Health
Associate Scientist III
Integrated Resources INC
Associate Scientist III
Integrated Resources INC
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Scientist I - RNA Therapeutic Discovery (4-month contract)
Ascidian Therapeutics
